Deutsch
Englisch
| 2017 |
|---|
| Kok, H., Van Den Hoogen, L., Van Roon, J., Adriaansen, E., Fritsch-Stork, R., Goldschmeding, R., Radstake, T., & Bovenschen, N. (2017). Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus. Rheumatology (Oxford), 56(12), 2129-2134. doi: 10.1093/rheumatology/kex332 |
| Kroese, S. J., Abheiden, C. N. H., Blomjous, B. S., Van Laar, J. M., Derksen, R. W. H. M., Bultink, I. E. M., Voskuyl, A. E., Lely, A. T., De Boer, M. A., De Vries, J. I. P., & Fritsch-Stork, R. (2017). Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study. J Immunol Res., 2017(Epub ahead of print), 8245879. doi: 10.1155/2017/8245879 |
| Kroese, S. J., De Hair, M. J. H., Limper, M., Lely, A. T., Van Laar, J. M., Derksen, R. H. W. M., & Fritsch-Stork, R. D. E. (2017). Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. J Immunol Res, 2017(Epub ahead of print), 2810202. doi: 10.1155/2017/2810202 |
| Otten, H., Brummelhuis, W., Fritsch-Stork, R., Leavis, H., Wisse, B., Van Laar, J., & Derksen, R. (2017). Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?. Clin Exp Rheumatol, 35(3), 462-470. |
| Teng, Y., Bredewol, E., Rabelink, T., Huizinga, T., Eikenboom, H., Limper, M., Fritsch-Stork, R., Bloemenkamp, K., & Sueters, M. (2017). An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus. Rheumatology (Oxford), -(Epub ahead of print), -. doi: 10.1093/rheumatology/kex374 |
| Yousef Yengej, F., Van Royen-Kerkhof, A., Derksen, R., & Fritsch-Stork, R. (2017). The development of offspring from mothers with systemic lupus erythematosus. A systematic review. Autoimmun Rev., 16(7), 701-711. doi: 10.1016/j.autrev.2017.05.005 |
| 2016 |
| Cuppen, B. V., Rossato, M., Fritsch-Stork, R. D., Schenk, Y., Bijlsma, J. J., Radstake, T. R., & Lafeber, F. P. J. G. (2016). Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?. Arthritis Research and Therapy, 18(1), 189. doi: 10.1186/s13075-016-1085-z (IF: 4.2) |
| Fu, J., Cuppen, B., Welsing, P., Van Wietmarschen, H., Harms, A., Berger, R., Koval, S., Fritsch-Stork, R., Bijlsma, J., Hankemeier, T., Van Der Greef, J., & Lafeber, F. (2016). Differences between serum polar lipid profiles of male and female rheumatoid arthritis patients in response to glucocorticoid treatment. Inflammopharmacology, 24(6), 397-402. doi: 10.1007/s10787-016-0284-1 |
| Van Den Hoogen, L. L., Fritsch-Stork, R. D., Versnel, M. A., Derksen, R. H. W., Van Roon, J. A. G., & Radstake, T. R. D. (2016). Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use. Annals of the Rheumatic Diseases, 75(12), e82-e82. doi: doi:10.1136/annrheumdis-2016-210485 (IF: 12.8) |